Nick Abbott
Stock Analyst at Wells Fargo
(0.10)
# 4,496
Out of 5,149 analysts
4
Total ratings
25%
Success rate
-33.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nick Abbott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Assumes: Overweight | $45 → $9 | $24.45 | -63.19% | 1 | Oct 4, 2022 | |
| TCRT Alaunos Therapeutics | Assumes: Overweight | $450 | $3.35 | +13,332.84% | 2 | Oct 4, 2022 | |
| CLLS Cellectis | Downgrades: Equal-Weight | $16 | $3.66 | +337.16% | 1 | Jan 6, 2022 |
Zymeworks
Oct 4, 2022
Assumes: Overweight
Price Target: $45 → $9
Current: $24.45
Upside: -63.19%
Alaunos Therapeutics
Oct 4, 2022
Assumes: Overweight
Price Target: $450
Current: $3.35
Upside: +13,332.84%
Cellectis
Jan 6, 2022
Downgrades: Equal-Weight
Price Target: $16
Current: $3.66
Upside: +337.16%